InvestorsHub Logo

123tom

09/18/17 2:45 AM

#120611 RE: XenaLives #120610

Excellent post...should be ...


stickied ( in 2 days).
Everyone should take the time to read those comments by Gottlieb.

Investor2014

09/18/17 3:08 AM

#120612 RE: XenaLives #120610

It would be fantastic soon to read Anavex PR matching what Gottlieb has said here and you highlighted!

I would say the odds of that happening are worth the wait.

Fireman02360

09/18/17 6:23 AM

#120613 RE: XenaLives #120610

Seems like this is the path Missling is ALREADY taking us down.

Great post Xena, very informative.

-Fireman

xodcode

09/18/17 6:37 AM

#120614 RE: XenaLives #120610

Is it just me, or does it seem like CM's handwriting is all over that Scott Gottlieb release.

SquealingSquid

09/18/17 6:56 AM

#120615 RE: XenaLives #120610

Sounds like Anavex would be a perfect fit and is already doing many of things that Gottlieb is talking about

nidan7500

09/18/17 7:57 AM

#120619 RE: XenaLives #120610

Gotta like this:

These methods have been used with some of the newer immunological therapies. It may also be used in other drugs targeted against specific molecular defects. Seamless designs are particularly advantageous for drugs that work in a variety of diseases, allowing rapid evaluation of the drug and potential approval under our accelerated approval pathway. These new approaches are also highly consistent with the goals of the 21st Century Cures Act and the recently passed FDA Reauthorization Act.


samk

09/18/17 9:17 AM

#120623 RE: XenaLives #120610

priceless find, XenaLives